UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-QSB/A

Quarterly Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

For the quarterly period ended June 30, 2005

Commission file Number 00114800

CYTATION CORPORATION
(Exact Name of Registrant as Specified in its Charter)



|Delaware                                       | 16-0961436                             
|---------------------------------------------- | ---------------------------------------
|(State or Other Jurisdiction of Incorporation) | (I.R.S. Employer Identification
Number)

251 Thames Street, No. 8, Bristol, RI 02809 (Address of
Principal Executive Offices) (Zip Code)

(401) 254-8800 (Registrant's Telephone Number, Including
Area Code)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

YES [X] NO [ ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practical date:

Common Stock, $.001 Par Value - 476,331 shares as of August 4, 2005.



FORWARD-LOOKING INFORMATION

THIS FORM 10-QSB/A AND OTHER STATEMENTS ISSUED OR MADE FROM TIME
TO TIME BY CYTATION CORPORATION OR ITS REPRESENTATIVES CONTAIN STATEMENTS WHICH
MAY CONSTITUTE "FORWARD-LOOKING STATEMENTS" WITHIN THE MEANING OF THE SECURITIES
ACT OF 1933 AND THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED BY THE PRIVATE
SECURITIES LITIGATION REFORM ACT OF 1995. FIFTEEN U.S.C.A. SECTIONS 77Z-2 AND
78U-5 (SUPP. 1996). THOSE STATEMENTS INCLUDE STATEMENTS REGARDING THE INTENT,
BELIEF OR CURRENT EXPECTATIONS OF CYTATION CORPORATION AND MEMBERS OF ITS
MANAGEMENT TEAM AS WELL AS THE ASSUMPTIONS ON WHICH SUCH STATEMENTS ARE BASED.
PROSPECTIVE INVESTORS ARE CAUTIONED THAT ANY SUCH FORWARD-LOOKING STATEMENTS ARE
NOT GUARANTEES OF FUTURE PERFORMANCE AND INVOLVE RISKS AND UNCERTAINTIES, AND
THAT ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE CONTEMPLATED BY SUCH
FORWARD-LOOKING STATEMENTS. THE COMPANY UNDERTAKES NO OBLIGATION TO UPDATE OR
REVISE FORWARD-LOOKING STATEMENTS TO REFLECT CHANGED ASSUMPTIONS, THE OCCURRENCE
OF UNANTICIPATED EVENTS OR CHANGES TO FUTURE OPERATING RESULTS OVER
TIME.

REVOCATION OF LETTER OF INTENT

THE COMPANY HAS TERMINATED ITS LETTER OF INTENT WITH EVOLVE ONCOLOGY, INC.
AND REVOKED THE FORWARD STOCK DIVIDEND AS DESCRIBED HEREIN.

ON APRIL 8, 2005, THE COMPANY ENTERED INTO A BINDING LETTER OF INTENT WITH
EVOLVE ONCOLOGY, INC. ("EVOLVE") (PINK SHEETS: "EVON") TO EFFECT A TRANSACTION
WITH EVOLVE PURSUANT TO WHICH A SUBSTANTIALLY MAJORITY OF THE EQUITY OF THE
COMPANY WOULD BE OWNED BY THE EVOLVE STOCKHOLDERS. THE COMPANY WILL BE THE
SURVIVING CORPORATION UNDER THE PROPOSED TRANSACTION, WOULD AUTHORIZE ADDITIONAL
SHARES OF COMMON STOCK TO BE ISSUED IN THE TRANSACTION, DECLARE A 2.5 FOR ONE
FORWARD STOCK SPLIT, AND ISSUE TO EVOLVE'S STOCKHOLDERS APPROXIMATELY 20,800,000
NEWLY ISSUED SHARES OF ITS COMMON STOCK. EVOLVE AGREED TO ASSUME AND TO PAY
APPROXIMATELY $115,000 OF THE COMPANY'S LIABILITIES AT THE CLOSING OF THE
TRANSACTION. AFTER THE TRANSACTION, STOCKHOLDERS OF EVOLVE WOULD OWN
APPROXIMATELY 95% OF THE TOTAL ISSUED AND OUTSTANDING COMMON STOCK OF THE
COMPANY.

SUBSEQUENTLY, THE TERMS OF THE PROPOSED TRANSACTION WERE MODIFIED AND THE
BOARD OF DIRECTORS OF THE COMPANY AUTHORIZED A 3.75-FOR-1 FORWARD STOCK DIVIDEND
TO STOCKHOLDERS OF RECORD ON AUGUST 8, 2005. THE PAYMENT DATE FOR THE STOCK
DIVIDEND IS AUGUST 22, 2005. EVOLVE ALSO AGREED TO MAKE A CASH PAYMENT TO THE
COMPANY OF $125,000, SUBSTANTIALLY ALL OF WHICH WILL BE USED TO DISCHARGE
INDEBTEDNESS AT THE CLOSING.

The Company will continue to seek to close a reverse merger or
comparable transaction.



PART 1 FINANCIAL INFORMATION

Item 1.  Financial Statements.

Cytation Corporation

CONTENTS

UNAUDITED FINANCIAL STATEMENTS

Balance Sheets as of June 30, 2005 and December 31,
2004     Statements of Operations for the Three
Months Ended June 30, 2005 and 2004

Statement of Operations for theSix Months Ended June 30, 2005 and 2004     Statements of Cash Flows for the
Six Months Ended June 30, 2005 and
2004     Notes to Financial
Statements

---

Cytation
      CorporationBalance
      SheetsASSETSJune 30,
    
    December
    31,2005
    
    2004(Unaudited)
    
    (Audited)CURRENT ASSETS:Cash
    $
    2,596
    $
    65,644Notes receivable,
    stockholders
    
    -
    
    10,113Notes receivable, others
    
    -
    
    5,000Prepaid expenses and other current
      assets
    
    -
    
    8,706Total
      Current Assets
    
    2,596
    
    89,463PROPERTY AND EQUIPMENT, Net
    
    -
    
    4,496OTHER ASSETS:Security deposit
    
    1,800
    
    1,800Investment in privately-held
      companies
    
    -
    
    59,7181,800
    
    61,518TOTAL
      ASSETS
    $
    4,396
    $
    155,477============
    
    =============LIABILITIES AND
      STOCKHOLDERS' DEFICITCURRENT LIABILITIES:Accounts payable and accrued
      expenses
    $
    45,165
    $
    92,306Note payable and accrued
      interest
    
    122,997
    
    120,228Total
      Current Liabilities
    
    168,162
    
    212,534COMMITMENTS AND CONTINGENCIES
    
    -
    
    -STOCKHOLDERS' DEFICIT:Common stock, $0.001 par value,
      2,000,000 shares authorized,476,331 and 436,165
      shares issued and outstanding, respectively
    
    477
    
    436Additional paid-in capital
    
    32,652,243
    
    32,608,451Accumulated deficit
    
    (32,816,486)
    
    (32,665,944)TOTAL
      STOCKHOLDERS' DEFICIT
    
    (163,766)
    
    (57,057)TOTAL
      LIABILITIES AND STOCKHOLDERS' DEFICIT
    $
    4,396
    $
    155,477============
    
    =============See notes to financial
      statements.


---



Cytation
      CorporationStatements of OperationsFor
      The Three Months Ended June 30, 2005 and 2004(Unaudited)2005
    
    2004CONSULTING REVENUE
    $
    -
    $
    36,900COST OF REVENUE
    
    375
    
    274,799GROSS PROFIT
    
    (375)
    
    (237,899)OPERATING EXPENSES:Depreciation
    
    525
    
    945Selling, general and
      administrative
    
    106,594
    
    66,655TOTAL
      OPERATING EXPENSES
    
    107,119
    
    67,600OPERATING
      LOSS
    
    (107,494)
    
    (305,499)OTHER INCOME (EXPENSES)Gain on sale of investment
    
    -
    
    82,391Loss on sale of property and
      equipment
    
    (4,270)
    
    -Interest income (expenses),
    net
    
    (1,385)
    
    (1,384)TOTAL
      OTHER INCOME (EXPENSES)
    
    (5,655)
    
    81,007LOSS
      BEFORE INCOME TAXES
    
    (113,149)
    
    (224,492)INCOME TAXES
    
    -
    
    -NET
      LOSS
    $
    (113,149)
    $
    (224,492)=========
    
    ==========Net
      (Loss) Income Per Share (Basic and Diluted)
    $
    (0.25)
    $
    (0.51)=========
    
    ==========Weighted Average Common Shares Outstanding
    
    461,331
    
    436,165=========
    
    ==========See notes to financial
      statements.


---



Cytation CorporationStatements of OperationsFor
      The Six Months Ended June 30, 2005 and 2004(Unaudited)2005
    
    2004CONSULTING REVENUE
    $
    -
    $
    41,900COST OF REVENUE
    
    1,557
    
    720,204GROSS PROFIT
    
    (1,557)
    
    (678,304)OPERATING EXPENSES:Depreciation
    
    1,037
    
    1,749Selling, general and
      administrative
    
    135,404
    
    175,834TOTAL
      OPERATING EXPENSES
    
    136,441
    
    177,583OPERATING
      LOSS
    
    (137,998)
    
    (855,887)OTHER INCOME (EXPENSES)Gain on sale of investment
    
    -
    
    348,641Loss on sale of property and
      equipment
    
    (4,270)
    
    -Loss on termination of ARE
      agreement
    
    (5,000)
    
    -Interest income (expenses),
    net
    
    (3,274)
    
    (2,770)TOTAL
      OTHER INCOME (EXPENSES)
    
    (12,544)
    
    345,871LOSS
      BEFORE INCOME TAXES
    
    (150,542)
    
    (510,016)INCOME TAXES
    
    -
    
    -NET
      LOSS
    $
    (150,542)
    $
    (510,016)=========
    
    =========Net
      (Loss) Income Per Share (Basic and Diluted)
    $
    (0.34)
    $
    (1.40)=========
    
    =========Weighted Average Common Shares Outstanding
    
    449,072
    
    364,471=========
    
    =========See notes to financial
      statements.


---



Cytation CorporationStatements of Cash FlowsFor The Six Months Ended June 30, 2005 and
      2004(Unaudited)2005
    
    2004CASH FLOWS FROM OPERATING
    ACTIVITIES:Net
    loss
    $
    (150,542)
    $
    (510,016)Adjustments to
      reconcile net loss to net cashused in operating
      activities:Depreciation
    
    1,036
    
    1,749Gain on
      sale of investment
    
    -
    
    (348,640)Stock
      based compensation
    
    20,333
    
    72,000Accrued
      interest on note payable
    
    2,770
    
    2,772Loss on
      termination of ARE agreement
    
    5,000
    
    -Loss on
      sale of property and equipment
    
    4,270Non-cash
      consulting income
    
    -
    
    (5,000)Non-cash
      consulting fee
    
    64,830
    
    719,000Changes in
      operating assets and liabilities:Accounts
      receivable
    
    
    
    (11,900)Prepaid
      expenses and others
    
    8,706
    
    -Accounts
      payable and accrued expenses
    
    (47,141)
    
    9,306NET
      CASH USED IN OPERATING ACTIVITIES
    
    (90,738)
    
    (70,729)CASH FLOWS FROM INVESTING
    ACTIVITIES:Proceeds from
      sale of marketable securities
    
    -
    
    80,997Proceeds from
      sale of property and equipment
    
    2
    
    -Purchases of
      property and equipment
    
    (812)
    
    (4,527)NET
      CASH USED IN INVESTING ACTIVITIES
    
    (810)
    
    76,470CASH FLOWS FROM FINANCING
    ACTIVITIES:Collections of
      notes receivable
    
    5,000
    
    9,885Proceeds from
      issuance of common stock
    
    23,500
    
    25NET
      CASH PROVIDED BY FINANCING ACTIVITIES
    
    28,500
    
    9,910NET
      DECREASE (INCREASE) IN CASH
    
    (63,048)
    
    15,651CASH, Beginning
    
    65,644
    
    2,236CASH, Ending
    $
    2,596
    $
    17,887==========
    
    ==========SUPPLEMENTAL DISCLOSURE OF CASH FLOW
      INFORMATION:Cash paid
      during the periods for:Interest
    $
    828
    $
    -==========
    
    ==========Taxes
    $
    -
    $
    -==========
    
    ==========Non-cash
      investing and financing activities:Distribution of
      investment to shareholders as dividend
    $
    -
    $
    582,330==========
    
    ==========See notes to financial
      statements.


---

Notes to Financial Statements

1.  Basis of Presentation

The accompanying unaudited financial
statements of Cytation Corporation (the "Company") have been prepared in
accordance with generally accounting principles for interim financial
information and with the instructions to prepare them for inclusion as part of
the Form 10QSB/A. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements. The financial statements for the periods ended June 30,
2005 and 2004 are unaudited and include all adjustments which in the opinion of
management, are necessary in order to make the financial statements not
misleading. All such adjustments are of a normal recurring nature. The results
of the Company's operations for any interim period are not necessarily
indicative of the results of the Company's operations for a full year. For
further information, refer to the financial statements and footnotes thereto
included in the Company's Form 10KSB filed with the Securities and Exchange
Commission for the period ended December 31, 2004.

2.  The Company

Until June 20, 2001, the Company provided
an extensive range of in-school and online services directed at high school
students and their parents, high school counselors, college admissions officers
and corporations which target with the teen marketplace. On June 20, 2001, the
Company sold all of its assets associated with these activities to TMP Worldwide
Inc. for approximately $7.2 million in cash and debt assumed.

During the period commencing with the
fourth quarter of 2002 and ending in December 2004, the Company engaged in the
business of providing consulting and related services to private companies that
wish to become reporting companies under the Securities Exchange Act of 1934. In
the first quarter of 2005, the Company discontinued all business operations and
agreed to engage in a reverse merger transaction, which was subsequently
abandoned.. See "Subsequent Events".

3.  Equity Transactions

On February 14, 2005, the Company authorized the issuance for no consideration of 1,666 shares to Bost & Co., an unaffiliated third party, in settlement of a prior
investment. Also on February 14, 2005, the Company authorized the issuance for nominal consideration of 15,000 restricted shares of its common stock to Richard Parke in
consideration of his agreement to serve as a director of the Company..The Company recorded an expense of $20,333 in connection with the issuance of these shares. On March 4, 2005, the Company agreed to issue 23,500 of its common shares to
an unaffiliated third party for $23,500 in cash and a warrant to purchase 20,000 shares of the common stock of Solomon Technologies, Inc ("Solomon Warrant"). All of these
shares were issued on June 30, 2005 when the market price of the Company's common stock was $1.22 per share. On September 1, 2005, the Solomon Warrant was issued and $2,634 was
recorded as a reduction of paid-in capital based on the Black-Scholes option valuation model.

4.  Investment/Termination of
Consulting Agreement

In the first quarter of 2004, the Company
received 500,000 restricted shares of common stock and warrants of an unrelated
entity, American Radio Empire, Inc. ("ARE"), as compensation for the consulting
services provided and to be provided. The investment was valued at $5,000, which
management believes is approximately the fair value of the shares at this time,
and this amount was recorded as consulting revenue on the accompanying financial
statements. During the first quarter of 2005, the Company returned the 500,000
restricted shares of ARE common stock and entered into a mutual release
agreement with ARE pursuant to which each party released all claims against the
other.

5.  Termination of Letter of
Intent

During the first quarter of 2005, the
Company reviewed business opportunities resulting from its status as a Business
Development Company under the Investment Company Act of 1940 and evaluated other
courses of action. On April 8, 2005, the Company entered into a binding letter
of intent with Evolve Oncology, Inc. ("Evolve") to effect a transaction with
Evolve pursuant to which the Company will not engage in any further business
operations other than to close the transaction. Although the Company will be the
surviving corporation under the proposed transaction, it will not thereafter
engage in any business that it has engaged in the past. Stockholders of the
Company will be substantially diluted, and the Company's current officers and
directors will resign. The Company will authorize additional shares of common
stock to be issued in the transaction, declare a 2.5 for one forward stock
split, and issue to Evolve's stockholders approximately 20,800,000 newly issued
shares of its common stock. Evolve has agreed to assume and to pay approximately
$115,000 of the Company's liabilities at the closing of the transaction. After
the transaction, stockholders of Evolve would own approximately 95% of the total
issued and outstanding common stock of the Company.

Subsequently, the terms of the proposed
agreement were modified, and the Board of Directors of the Company authorized a
3.75-for-1 forward stock dividend for stockholders of record on August 8, 2005.
The payment date for the dividend is August 22, 2005. Under the modified
agreement, the stockholders of the Company will own approximately 8% of the
equity securities after the transaction. The transaction has not closed as of
the date hereof, and no assurance can be provided that it will
close.

Thereafter, the Company terminated the letter of intent with Evolve and
revoked its authorization for the forward stock dividend.

6.  Other Events

In contemplation of the Evolve
transaction, and as compensation for prior services to its two officers, the
Company cancelled $10,111 of debt, distributed approximately $17,000 of the
common stock of Hydrogen Technology Applications, Inc. and sold assets to them
with an approximate book value of $4,600 for a nominal price. The Company also
distributed to unaffiliated third parties approximately $37,500 of the common
stock of Hydrogen Technology Applications, Inc. for prior
services.

Item 2.  Management's Discussion and Analysis or Plan of
Operation.Results of Operations

As a result of the Company's decision to
discontinue all business operations and to seek to enter into a reverse merger
or comparable transaction, the Company no longer is engaged in any business in
which it was engaged during its last three fiscal years. Accordingly, management
does not believe that it is informative or useful to compare the results of
operations of its former principal business with the results of operations
during the second quarter and first six months of 2005, when its decided to
terminate its business and engage in a reverse merger transaction.

Liquidity and Capital Resources As of June 30, 2005, we had negative working capital of $165,566 compared
to positive working capital of $19,166 as of June 30, 2004.

We have minimal fixed expenses and
minimal operating costs. We expect to be able to operate until the closing of a
reverse merger or similar transaction. Our officers serve as consultants to us
and are not paid. We occupy our office space on a month-to-month basis. The
Company has no employment or consulting agreements or long-term commitments for
office space or services.

Item 3.  Controls and Procedures

As required by Rule 13a-15 under the
Exchange Act, as of the end of the period covered by this report for the quarter
ended June 30, 2005, we have carried out an evaluation of the effectiveness of
the design and operation of our disclosure controls and procedures. This
evaluation was carried out under the supervision and with the participation of
our management, including our President along with our Chairman and General
Counsel. Based upon that evaluation, our President along with our Chairman and
General Counsel concluded that our disclosure controls and procedures are
effective as at the end of the period covered by this report. There have been no
significant changes in our internal controls or in other factors, which could
significantly affect internal controls subsequent to the date we carried our
evaluation.

Disclosure controls and procedures and
other procedures that are designed to ensure that information required to be
disclosed in our reports filed or submitted under the Exchange Act is recorded,
processed, summarized and reported, within the time period specified in the
Securities and Exchange Commission's rules and forms. Disclosure controls and
procedures include, without limitation, controls and procedures designed to
ensure that information required to be disclosed in our reports filed under the
Exchange Act is accumulated and communicated to management, including our
President and Chairman and General Counsel, as appropriate, to allow timely
decisions regarding required disclosure.

PART II OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 2. Change in Securities.

On February 14, 2005, the Company authorized the issuance of 15,000 shares to
Richard Parke in consideration of his agreement to join the Company's board of
directors. The purchase price of these shares was $15.00. On February 14, 2005,
the Company authorized the issuance for no consideration of 1,666 shares to Bost
& Co., an unaffiliated third party, in consideration of a prior investment.
On March 4, 2004, the Company agreed to issue 23,500 of its common shares to an
unaffiliated third party for $23,500. All of these shares were issued in the
quarter ending June 30, 2005.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Submission of Matters to a Vote of Security Holders.

None.

Item 5. Other Information.

Certification under Sarbanes-Oxley Act.  Our president and our
chairman of the board and chief financial officer have furnished to the SEC the
certification with respect to this Report that is required by Section 906 of the
Sarbanes-Oxley Act of 2002. Item 6. Exhibits and Reports on Form
8-K.

The following exhibits are filed as part
of or incorporated by reference into this Report:



Exhibit
    Description3.1
    Amended and Restated Certificate of
      Incorporation of the Company(2)3.2
    Articles of Merger between the
      Company and Cytation Corporation, dated February 11,
  1999(1)3.3
    Articles of Merger between
      CollegeLink.com Incorporated and ECI, Inc., dated August 10,
      1999(2)3.4
    Certificate of Merger of
      CollegeLink.com Incorporated and ECI, Inc., dated August 10,
      1999(2)3.5
    Certificate of Ownership and Merger
      between the Company and CollegeLink.com Incorporated, dated November 15,
      1999(2)3.6
    By-Laws of the
    Company(2)4.1
    Please see Exhibits 3.1 and 3.6 for
      provisions of the Amended and Restated Certificate of Incorporation and
      By-Laws of the Company defining the rights of holders of the common stock
      of the Company10.1
    Consulting agreement dated March
      18, 2004 by and between Business Solutions of the Future Inc. and the
      Company


(1)  Incorporated by reference from the Company's Form 8-K,
Current Report, filed March 18, 1999, and later amended on April 2,
1999.(2)  Filed as Exhibit to the Company's Registration
Statement No. 333-85079 on Form SB-2 and incorporated herein by
reference.



(b)  Reports on Form 8-K



Form 8K,
Other Events, filed on August 1, 2005.

Form 8K,
Other Events, filed on August 4, 2005.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

CYTATION CORPORATION

By: /s/Richard A.
Fisher
       Name: Richard A. Fisher
       Title: Chairman of the Board and
Chief Financial Officer

Date: December 19, 2005